Last reviewed · How we verify

NCT06635018: PICOMP

Effect of Pulse Oximeter Device on Measured Perfusion Index Values

Completed NA Last updated 11 March 2026
What this trial tests

NA trial testing Resting conditions in Perfusion Index in 42 participants. Completed in 30 August 2025.

Timeline
1 February 2024
Primary endpoint
30 October 2024
30 August 2025

Quick facts

Lead sponsorCzech Technical University in Prague
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment42
Start date1 February 2024
Primary completion30 October 2024
Estimated completion30 August 2025
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Czech Technical University in Prague

Who can join

18 and older, any sex, with Perfusion Index. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to experimentally determine the effect of pulse oximeters from different manufacturers on measured perfusion index values in healthy subjects at rest and with and without motion artifacts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Resting conditions

Trials testing the same drug.

Other recruiting trials for Perfusion Index

Currently open trials in the same condition.

Other Czech Technical University in Prague trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing